+44 1300 500008Editor-in-Chief
Alexandra Lucas
Editor-in-Chief
Professor
University of Florida, Section Head Vascular Research
Biography
Dr. Lucas moved to the University of Florida in 2006_ from the Robarts Research Institute and University of Western Ontario in London,Ontario, Canada, where she has been a principal investigator studying inflammation, specifically monocyte and T lymphocyte activation in vascular disease. Dr. Lucas is also co-inventor and co-founding scientist for Viron Therapeutics, Inc., a biotechnology company that is now in clinical trial analyzing viral anti-inflammatory proteins as a new class of therapeutic agents. Dr. Lucas is a practicing interventional cardiologist in addition to running an active basic research lab in vascular inflammatory research with bovver 100 paper and reviews and 16 patents published. She has been an active member of the Canadian Society for Atherosclerosis and Thrombosis Board having also served as Editor-in-Chief and serves on the American Heart Association grant panel. She is additionally on the editorial board for several journals. Dr. Lucas also directs an annual medical mission to Fte. Liberte in Haiti.
Research Interest
Ion channels, Functional Genomics and Proteomics, Phenomics, Cardiac Electrophysiology and Pharmacology, Cardiac Ischemia, Cardioprotection, Myocardial Hypertrophy and Heart Failure.
Dayue Darrel Duan
Editor-in-Chief
Professor
University of Nevada,
Biography
Dayue Darrel Duan, MD (Hunan Medical University, 1982), MSc (Sun Yat- Sen University of Medical Sciences, 1987), PhD (McGill University, 1996), is a Professor of Pharmacology and Director of Laboratory of Cardiovascular Phonomics in the Center of Biomedical Research Excellence and the Department of Pharmacology, University of Nevada, Reno, USA. He is also a Visiting Professor of several prestigious universities in China, including Central South University XiangYa Medical College, Sun Yat-sen University, the Second Military Medical University, the Forth Military Medical University, and Harbin Medical University. He has been studying cellular and molecular electrophysiology and cardiovascular pharmacology for 25 years. He discovered several anion channels in the heart and has made significant contributions to the study of biophysics, physiology, pharmacology, and molecular biology of ion channels in the cardiovascular system. His current research, supported by NIH, American Heart Association, and American Diabetes Association, is focusing on the functional genomics, proteomics, and phenomics of ion channels in the cardiovascular systems. He has published more than 50 papers and book chapters. His publications often appear in the most prestigious journals including Nature, Physiological Review, Circulation, Circulation Research, Journal of Biological Chemistry, Journal of General Physiology, Journal of Physiology etc. He served on the Research Committee of the Western States Affiliate of American Heart Association. He is currently a member of the Editorial Board of Acta Pharmacologica Sinica, Proceedings of Western Pharmacological Society, and World Journal of Cardiology, and a frequent referee for more than 40 professional journals.
Research Interest
Ion channels, Functional Genomics and Proteomics, Phenomics, Cardiac Electrophysiology and Pharmacology, Cardiac Ischemia, Cardioprotection, Myocardial Hypertrophy and Heart Failure.
Grigorios Korosoglou
Editor-in-Chief
Professor, Department of Cardiology, Vascular Medicine & Cardiac MR Academic GRN Hospital
Academic GRN Hospital, Weinheim, Germany
Biography
Grigorios Korosoglou
Assistant Professor
University of Heidelberg
Department of Cardiology
Im Neuenheimer Feld 410
D-69120 Heidelberg, Germany
Research Interest
Cardiovascular Imaging (cardiac CT; cardiac MRI), Inteventional cardiology Vascular interventions